Verified July 2026 · Cited to primary sources

CJC-1295 / Ipamorelin: Evidence Grade CEarly / foreign human data only.

Grade CResearch-onlySafety: amber

The honest verdict

CJC-1295/Ipamorelin is not FDA-approved and is not legally compoundable (CJC-1295 withdrawn April 2026). Human evidence is Grade C — one PK study proves it raises GH/IGF-1, but no trial shows muscle or fat-loss benefit. Researching CJC-1295 on its own (often "with DAC")? See our standalone CJC-1295 page.

CJC-1295 / Ipamorelin at a glance

Class
GHRH analog (CJC-1295) stacked with a selective GH secretagogue (Ipamorelin)
Mechanism
CJC-1295 (a GHRH analog) drives sustained pituitary GH/IGF-1 release while Ipamorelin (a selective ghrelin/GHS-R agonist) adds a clean GH pulse — the stack aims to raise GH/IGF-1.
Also known as
CJC-1295 (Mod-GRF 1-29), CJC-1295 DAC, Ipamorelin stack
Research applications
  • Muscle growth and body recomposition (marketed; no efficacy RCT)
  • GH optimization / anti-aging (claimed; unproven)
Forms
subcutaneous injection
Legal status
Research-only
WADA (anti-doping)
Prohibited (S2 — GHRH analog / GH secretagogue) at all times
Evidence grade
Grade CEarly / foreign human data only

How we grade evidence

Every grade is assigned by a fixed A–F rubric — human-trial strength, not hype or affiliate status. Last verified July 6, 2026.

What is CJC-1295 / Ipamorelin?

The classic GH-boosting stack — one human PK study shows it raises GH/IGF-1, but no trial shows it builds muscle or burns fat.

CJC-1295 (a GHRH analog) drives sustained pituitary GH/IGF-1 release while Ipamorelin (a selective ghrelin/GHS-R agonist) adds a clean GH pulse — the stack aims to raise GH/IGF-1.

How strong is the evidence for CJC-1295 / Ipamorelin?

Graded to the stronger component. CJC-1295 has one published human PK study showing GH/IGF-1 elevation (Grade C — early human data, rule 4). Ipamorelin has only limited early-phase human development (Grade D). Neither has an efficacy RCT for muscle, fat, or anti-aging — the marketed benefits are unproven.

Primary sources (4)

  1. FDA 503A bulks list (fda.gov/media/94155/download)
  2. Federal Register FDA-2025-N-6895 (April 2026 503A reclassification)
  3. WADA Prohibited List (S2 — GHRH analog / GH secretagogue)
  4. Teichman et al., J Clin Endocrinol Metab 2006 — CJC-1295 human PK study

What is CJC-1295 / Ipamorelin used for?

CJC-1295 / Ipamorelin is marketed for the goals below. See how it ranks against other peptides in each — by evidence, not hype.

What does CJC-1295 / Ipamorelin cost — and how do you access it legally?

Typical cost

$200–$400/month (stack)

CJC-1295/Ipamorelin stack pricing ~$200–$400/month (~$445/cycle) per seekpeptides.com; access is gray-market given the 503A status.

No legal supervised access route right now.

CJC-1295 / Ipamorelin has no compliant US route today. Vials sold "for research use only" are a gray-market fig-leaf, not a legal loophole — we don't link them. If you pursue CJC-1295 / Ipamorelin, do it with a licensed clinician, and re-check its legal status first.

Is CJC-1295 / Ipamorelinsafe? Side effects & risks

Limited human safety data, no major documented harms

GH-excess effects (edema, carpal tunnel, insulin resistance, IGF-1 elevation → theoretical cancer risk). A widely-cited adverse-event report exists for CJC-1295 DAC (causation unestablished). CJC-1295 nomination was withdrawn April 2026; Ipamorelin's status is conflicting/rejected. WADA-prohibited (S2).

Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.

FAQ

CJC-1295 / Ipamorelin FAQ

Is this the same as CJC-1295 on its own?

No. This page covers the popular stack — CJC-1295 (a GHRH analog) combined with Ipamorelin (a separate ghrelin/GH-secretagogue peptide). For CJC-1295 by itself, usually the long-acting "with DAC" version, see our dedicated CJC-1295 page.

Does CJC-1295/Ipamorelin build muscle?

There is no human trial showing it builds muscle or burns fat. The only human data is a pharmacokinetic study confirming it raises GH and IGF-1 levels — that is why we grade it C, not higher.

Is CJC-1295/Ipamorelin legal to get from a clinic?

Not through a compliant 503A route. CJC-1295's compounding nomination was withdrawn in April 2026 and PCAC previously voted against it, so it is effectively research-only. Any clinic openly selling it today is a compliance flag.

Is it banned in sport?

Yes. Both are on the WADA Prohibited List under S2 (GHRH analogs and GH secretagogues).

Compare CJC-1295 / Ipamorelin with…

Head-to-head evidence-grade matchups people weigh against CJC-1295 / Ipamorelin.

Keep reading

The monthly peptide evidence brief.

What the research and the FDA actually say — one short email a month. Unsubscribe anytime.

No spam. We never sell your email. Editorial policy.